Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in mechanically ventilated patients at high risk of delirium - Modifying Delirium Using Simvastatin - MoDUS

West Hertfordshire Hospitals NHS Trust0 个研究点目标入组 142 人开始时间: 2012年11月6日最近更新: 2020年2月1日

适应症

试验速览

暂无简介。

•Patients requiring mechanical ventilation within 72 hours of admission to intensive care.
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 62
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 80

•Age less than 18 years
•Patient known to be pregnant
•Known allergy to statin drugs
•CK > 10 times upper limit of normal range
•Alanine aminotransferase (ALT) >8 times the upper limit of normal range
•Patients currently receiving ongoing and sustained treatment with any of the following; itraconazole, ketoconazole, HIV protease inhibitors, nefazodone, cyclosporine, amiodarone, verapamil or diltiazem
•Uncomplicated elective surgery
•Patient expected to be discharged within 48 hours of admission
•Patients with severe renal impairment (estimated creatinine clearance less than 15ml/minute) not receiving renal replacement therapy
•Severe liver disease
•Current or recent treatment (within 2 weeks) with statins
•Physician decision that a statin is required for proven indication
•Contraindication to enteral drug administration, e.g. patients with mechanical bowel obstruction. Patients with high gastric aspirates due to an ileus are not excluded.
•Known participation in investigational medicinal product (IMP) trials within 30 days
•Consent declined
•Treatment withdrawal likely within 48 hours
•Non-English speaking patients or those who do not adequately understand verbal or written information.

发起方